Cytokine expression in otitis media with effusion: Tumor necrosis factor soluble receptor

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 9, 1997, Pages 984-988

  Maxwell, Kenneth ^a   Leonard, Gerald ^a   Kreutzer, Donald L ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; PATHOGENESIS; RADIOIMMUNOASSAY; REGULATORY MECHANISM; SECRETORY OTITIS MEDIA; TYMPANOSTOMY TUBE;

EID: 0030883579     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900090100015     Document Type: Article

References (13)

1. Yellon R, Leonard G, Marucha P, et al. Characterization of cytokines present in middle effusions. Laryngoscope. 1991;101:165-169.
2. Yellon R, Leonard G, Marucha P, et al. Demonstration of interleukin-6 in middle ear effusions. Arch Otolaryngol Head Neck Surg. 1992;118:745-748.
3. Ophir D, Hahn T, Schattner A, et al. Tumor necrosis factor in middle ear effusions. Arch Otolaryngol Head Neck Surg. 1988;114:1256-1258.
4. Juhn S, Tolan C, Garvis W, et al. The levels of IL-1 beta in human middle ear effusions. Acta Otolaryngol. 1992;493(suppl 2):37-42.
5. Maxwell K, Fitzgerald J, Burleson J, et al. Interleukin-8 expression in otitis media. Laryngoscope. 1994;104:989-995.
6. Thoma B, Grell M, Pfizenmaier K. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med. 1990;172:1019-1023.
7. Baughmann R, Lower E. An inhibitor of tumor necrosis factor found in pleural effusions. J Lab Clin Med. 1991;118:326-331.
8. Gatanga T, Lentz R, Masunaka I, et al. Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients. Lymphokine Res. 1990;9:225-229.
9. Cappucinni F, Yamamoto R, Disaia P, et al. Identification of tumor necrosis factor and lymphtoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Lymphokine Cytokine Res. 1991;10: 225-229.
10. Spinas G, Bloesch D, Kaufmann M, et al. Induction of plasma inhibitors of interleukin 1 and TNF-alpha activity by endotoxin administration to normal humans. Am J Physiol. 1990;259:993-997.
11. Seckinger P, Zhang J-H, Hauptmann B, et al. Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc Natl Acad Sci U S A. 1990;87:5188-5192.
12. Juhn SK, Gravis WJ, Lees CJ, Le CT, Kim CS. Determining otitis media severity from middle ear fluid analysis. Ann Otolaryngol Rhinol Larynol. 1994,163:43-45.
13. Seckinger P, Isaaz S, Dayer J-M. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem. 1989;264:11966-11973.